Is Calliditas Therapeutics AB (publ) (CALT) a Buy, Sell, or Hold?
NASDAQ : CALT
Calliditas Therapeutics AB (publ) — Analyst Ratings
$40.0001 USD
-$0.04 (-0.1%)
- Volume
- 9.8K
- Average Volume
- 7.59K
- Market Capitalization
- $2.15B
- P/E Ratio
- -21.92
- Dividend Yield
- 0.00%
- Price Target
- $39.50
- Year High
- $43.00
- Year Low
- $15.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
Analyst Consensus Summary
Consensus Rating
N/A
5 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
1.3%
vs Current Price
Price Target
$39.50
Average TargetPrice Target Range
Lowest Target
$39.00
2.6% UPSIDE
Average Target
$39.50
Median Estimate
Highest Target
$40.00
0.0% UPSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 5
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 0 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Maury Raycroft | $39 | $37.955 | 2024-05-28 09:15 AM | 2.8% |
| Stifel Nicolaus | Annabel Samimy | $40 | $38.06 | 2024-05-28 05:45 AM | 5.1% |
| Jefferies | Maury Raycroft | $58 | $22.7499 | 2024-05-23 10:38 AM | 154.9% |